Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson's disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.
A case of iatrogenic severe mitral regurgitation / D'Aloia, A; Piovanelli, B; Rovetta, R; Bonadei, Ivano; Vizzardi, Enrico; Curnis, Antonio; Metra, Marco. - In: MONALDI ARCHIVES FOR CHEST DISEASE. - ISSN 1122-0643. - 80:3(2014), pp. 133-136. [10.4081/monaldi.2013.75]
A case of iatrogenic severe mitral regurgitation
METRA, Marco
2014-01-01
Abstract
Bromocriptine and cabergoline, ergot derived dopamine receptor agonists used to treat Parkinson's disease and prolactinomas, have been associated with increased risk of cardiac valve disease. Here we present a case of iatrogenic symptomatic severe mitral regurgitation due to these drugs.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
